These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31054426)

  • 1. Fluoro-benzimidazole derivatives to cure Alzheimer's disease: In-silico studies, synthesis, structure-activity relationship and in vivo evaluation for β secretase enzyme inhibition.
    Ali S; Asad MHHB; Maity S; Zada W; Rizvanov AA; Iqbal J; Babak B; Hussain I
    Bioorg Chem; 2019 Jul; 88():102936. PubMed ID: 31054426
    [No Abstract]   [Full Text] [Related]  

  • 2. Discovery of highly potent human glutaminyl cyclase (QC) inhibitors as anti-Alzheimer's agents by the combination of pharmacophore-based and structure-based design.
    Van Manh N; Hoang VH; Ngo VTH; Ann J; Jang TH; Ha JH; Song JY; Ha HJ; Kim H; Kim YH; Lee J; Lee J
    Eur J Med Chem; 2021 Dec; 226():113819. PubMed ID: 34536669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semi-synthetic isoflavones as BACE-1 inhibitors against Alzheimer's disease.
    Ribaudo G; Coghi P; Zanforlin E; Law BYK; Wu YYJ; Han Y; Qiu AC; Qu YQ; Zagotto G; Wong VKW
    Bioorg Chem; 2019 Jun; 87():474-483. PubMed ID: 30927588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Studies on Design and Development of Drugs Against Alzheimer's Disease (AD) Based on Inhibition of BACE-1 and Other AD-causative Agents.
    Gupta SP; Patil VM
    Curr Top Med Chem; 2020; 20(13):1195-1213. PubMed ID: 32297584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorinated benzophenone derivatives: balanced multipotent agents for Alzheimer's disease.
    Belluti F; De Simone A; Tarozzi A; Bartolini M; Djemil A; Bisi A; Gobbi S; Montanari S; Cavalli A; Andrisano V; Bottegoni G; Rampa A
    Eur J Med Chem; 2014 May; 78():157-66. PubMed ID: 24681980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel multi-targeted agents for Alzheimer's disease: Synthesis, biological evaluation, and molecular modeling of novel 2-[4-(4-substitutedpiperazin-1-yl)phenyl]benzimidazoles.
    Ozadali-Sari K; Tüylü Küçükkılınç T; Ayazgok B; Balkan A; Unsal-Tan O
    Bioorg Chem; 2017 Jun; 72():208-214. PubMed ID: 28478328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional iminochromene-2H-carboxamide derivatives containing different aminomethylene triazole with BACE1 inhibitory, neuroprotective and metal chelating properties targeting Alzheimer's disease.
    Iraji A; Firuzi O; Khoshneviszadeh M; Tavakkoli M; Mahdavi M; Nadri H; Edraki N; Miri R
    Eur J Med Chem; 2017 Dec; 141():690-702. PubMed ID: 29107423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer's disease.
    Mayer SC; Kreft AF; Harrison B; Abou-Gharbia M; Antane M; Aschmies S; Atchison K; Chlenov M; Cole DC; Comery T; Diamantidis G; Ellingboe J; Fan K; Galante R; Gonzales C; Ho DM; Hoke ME; Hu Y; Huryn D; Jain U; Jin M; Kremer K; Kubrak D; Lin M; Lu P; Magolda R; Martone R; Moore W; Oganesian A; Pangalos MN; Porte A; Reinhart P; Resnick L; Riddell DR; Sonnenberg-Reines J; Stock JR; Sun SC; Wagner E; Wang T; Woller K; Xu Z; Zaleska MM; Zeldis J; Zhang M; Zhou H; Jacobsen JS
    J Med Chem; 2008 Dec; 51(23):7348-51. PubMed ID: 19012391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing Mechanisms and Therapeutic Potential of γ-Secretase in Alzheimer's Disease.
    Wolfe MS
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33450968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From Kinase Inhibitors to Multitarget Ligands as Powerful Drug Leads for Alzheimer's Disease using Protein-Templated Synthesis.
    Nozal V; García-Rubia A; Cuevas EP; Pérez C; Tosat-Bitrián C; Bartolomé F; Carro E; Ramírez D; Palomo V; Martínez A
    Angew Chem Int Ed Engl; 2021 Aug; 60(35):19344-19354. PubMed ID: 34169618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel tetrahydrocarbazole benzyl pyridine hybrids as potent and selective butryl cholinesterase inhibitors with neuroprotective and β-secretase inhibition activities.
    Ghobadian R; Mahdavi M; Nadri H; Moradi A; Edraki N; Akbarzadeh T; Sharifzadeh M; Bukhari SNA; Amini M
    Eur J Med Chem; 2018 Jul; 155():49-60. PubMed ID: 29857276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New flavonoid -
    Estrada-Valencia M; Herrera-Arozamena C; Pérez C; Viña D; Morales-García JA; Pérez-Castillo A; Ramos E; Romero A; Laurini E; Pricl S; Rodríguez-Franco MI
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):712-727. PubMed ID: 31852270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Structural Modification of BACE1 Inhibitors.
    Gu T; Wu WY; Dong ZX; Yu SP; Sun Y; Zhong Y; Lu YT; Li NG
    Molecules; 2016 Dec; 22(1):. PubMed ID: 28025519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-silico Studies and Biological Activity of Potential BACE-1 Inhibitors.
    Arya R; Paliwal S; Gupta SP; Sharma S; Madan K; Mishra A; Verma K; Chauhan N
    Comb Chem High Throughput Screen; 2021; 24(5):729-736. PubMed ID: 32957879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfonimidamides as sulfonamides bioisosteres: rational evaluation through synthetic, in vitro, and in vivo studies with γ-secretase inhibitors.
    Sehgelmeble F; Janson J; Ray C; Rosqvist S; Gustavsson S; Nilsson LI; Minidis A; Holenz J; Rotticci D; Lundkvist J; Arvidsson PI
    ChemMedChem; 2012 Mar; 7(3):396-9. PubMed ID: 22307979
    [No Abstract]   [Full Text] [Related]  

  • 16. Design, synthesis, and evaluation of tetrahydroquinoline and pyrrolidine sulfonamide carbamates as gamma-secretase inhibitors.
    Guo T; Gu H; Hobbs DW; Rokosz LL; Stauffer TM; Jacob B; Clader JW
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3010-3. PubMed ID: 17418571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuritogenic activity of bi-functional bis-tryptoline triazole.
    Jiaranaikulwanitch J; Tadtong S; Govitrapong P; Fokin VV; Vajragupta O
    Bioorg Med Chem; 2017 Feb; 25(3):1195-1201. PubMed ID: 28043778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monosubstituted γ-lactam and conformationally constrained 1,3-diaminopropan-2-ol transition-state isostere inhibitors of β-secretase (BACE).
    Boy KM; Guernon JM; Shi J; Toyn JH; Meredith JE; Barten DM; Burton CR; Albright CF; Marcinkeviciene J; Good AC; Tebben AJ; Muckelbauer JK; Camac DM; Lentz KA; Bronson JJ; Olson RE; Macor JE; Thompson LA
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6916-24. PubMed ID: 21782431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of tetrahydroisoquinoline-benzimidazole hybrids as multifunctional agents for the treatment of Alzheimer's disease.
    Fang Y; Zhou H; Gu Q; Xu J
    Eur J Med Chem; 2019 Apr; 167():133-145. PubMed ID: 30771601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New neurogenic lipoic-based hybrids as innovative Alzheimer's drugs with σ-1 agonism and β-secretase inhibition.
    Estrada M; Pérez C; Soriano E; Laurini E; Romano M; Pricl S; Morales-García JA; Pérez-Castillo A; Rodríguez-Franco MI
    Future Med Chem; 2016 Jul; 8(11):1191-207. PubMed ID: 27402296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.